Game-changer hits PBAC agenda

Posted 2 September 2024 AM

The PBAC September Intracycle Meeting has a couple of drugs on the agenda, along with a look at expanding who can prescribe certain medications - but all eyes will be on the Committee's consideration of game-changing access to cancer drugs. 

The agenda item is listed as providing "initial guidance on parameters that need to be considered for future broad PBS listing proposals for PD-(L)1 inhibitors, and to advise on next steps to seek broader stakeholder input".

To see the whole article, please login